Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557317
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Examining the Preliminary Efficacy of an In-Person Lifestyle Intervention for Black Female AdolescentCaregiver Dyads at Risk for Type 2 Diabetes Mellitus
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BGW In-Person
Brief Summary:
The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program
Detailed Description:
Enrolled adolescentcaregiver dyads will participate in the 12-week program Each week participants will engage in 2 activities an in-person Wellness Session and an at-home cooking experience using ingredients provided at the Wellness Session
The study will examine the pre-post difference in overall diet quality dermal carotenoid levels physical activity body composition and glycemic measures among at-risk black adolescent girls and their caregivers Investigators hypothesize that after the program participants diets will be higher in quality than before
The study will examine the pre-post difference in overall diet quality dermal carotenoid levels physical activity body composition and glycemic measures among at-risk black adolescent girls and their caregivers Investigators hypothesize that after the program participants diets will be higher in quality than before
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None